2.4.0.84090 - Disclosure - Commitments and Contingencies (Details)truefalsefalse1false USDfalsefalse$D2013Q2http://www.sec.gov/CIK0001344154duration2013-04-01T00:00:002013-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$D2013Q2YTDhttp://www.sec.gov/CIK0001344154duration2013-01-01T00:00:002013-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDtruefalse$D2013Q2_MerionCapitalLPMemberhttp://www.sec.gov/CIK0001344154duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseMerion Capital, L.Pus-gaap_RelatedPartyTransactionsByRelatedPartyAxisxbrldihttp://xbrl.org/2006/xbrldievh_MerionCapitalLPMemberus-gaap_RelatedPartyTransactionsByRelatedPartyAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDtruefalse$D2013Q2YTD_MerionCapitalLPMemberhttp://www.sec.gov/CIK0001344154duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseMerion Capital, L.Pus-gaap_RelatedPartyTransactionsByRelatedPartyAxisxbrldihttp://xbrl.org/2006/xbrldievh_MerionCapitalLPMemberus-gaap_RelatedPartyTransactionsByRelatedPartyAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDtruefalse$I2013Q2_M0415_MerionCapitalLPMemberhttp://www.sec.gov/CIK0001344154instant2013-04-15T00:00:000001-01-01T00:00:00falsefalseMerion Capital, L.Pus-gaap_RelatedPartyTransactionsByRelatedPartyAxisxbrldihttp://xbrl.org/2006/xbrldievh_MerionCapitalLPMemberus-gaap_RelatedPartyTransactionsByRelatedPartyAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6false truefalseD2010Q1_23M_AmericanMedicalResponseIncMember_PredecessorMemberhttp://www.sec.gov/CIK0001344154duration2008-04-16T00:00:002010-03-10T00:00:00falsefalseAMRdei_LegalEntityAxisxbrldihttp://xbrl.org/2006/xbrldievh_AmericanMedicalResponseIncMemberdei_LegalEntityAxisexplicitMemberfalsefalsePredecessorus-gaap_StatementScenarioAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PredecessorMemberus-gaap_StatementScenarioAxisexplicitMemberItemStandardhttp://www.envisionhealthcare.net/20130630itemevh07false USDtruefalse$D2006Q3_M0912_AmericanMedicalResponseIncMember_ViolationOfFederalAntiKickbackStatuteMember_PredecessorMemberhttp://www.sec.gov/CIK0001344154duration2006-09-11T00:00:002006-09-12T00:00:00falsefalseViolation of the federal anti-kickback statuteus-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldievh_ViolationOfFederalAntiKickbackStatuteMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberfalsefalseAMRdei_LegalEntityAxisxbrldihttp://xbrl.org/2006/xbrldievh_AmericanMedicalResponseIncMemberdei_LegalEntityAxisexplicitMemberfalsefalsePredecessorus-gaap_StatementScenarioAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PredecessorMemberus-gaap_StatementScenarioAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$8false truefalseD2006Q3_M09_AmericanMedicalResponseIncMember_ViolationOfFederalAntiKickbackStatuteMember_PredecessorMemberhttp://www.sec.gov/CIK0001344154duration2006-09-01T00:00:002006-09-30T00:00:00falsefalseViolation of the federal anti-kickback statuteus-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldievh_ViolationOfFederalAntiKickbackStatuteMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberfalsefalseAMRdei_LegalEntityAxisxbrldihttp://xbrl.org/2006/xbrldievh_AmericanMedicalResponseIncMemberdei_LegalEntityAxisexplicitMemberfalsefalsePredecessorus-gaap_StatementScenarioAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PredecessorMemberus-gaap_StatementScenarioAxisexplicitMember9false truefalseD2011Q2_M05_AmericanMedicalResponseIncMember_SubpoenaFromDepartmentOfJusticeMemberhttp://www.sec.gov/CIK0001344154duration2011-05-01T00:00:002011-05-31T00:00:00falsefalseSubpoena from the DOJus-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldievh_SubpoenaFromDepartmentOfJusticeMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberfalsefalseAMRdei_LegalEntityAxisxbrldihttp://xbrl.org/2006/xbrldievh_AmericanMedicalResponseIncMemberdei_LegalEntityAxisexplicitMember10false USDtruefalse$I2011Q2_M0520_AmericanMedicalResponseIncMember_SubpoenaFromDepartmentOfJusticeMember_PredecessorMemberhttp://www.sec.gov/CIK0001344154instant2011-05-20T00:00:000001-01-01T00:00:00falsefalseSubpoena from the DOJus-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldievh_SubpoenaFromDepartmentOfJusticeMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberfalsefalseAMRdei_LegalEntityAxisxbrldihttp://xbrl.org/2006/xbrldievh_AmericanMedicalResponseIncMemberdei_LegalEntityAxisexplicitMemberfalsefalsePredecessorus-gaap_StatementScenarioAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PredecessorMemberus-gaap_StatementScenarioAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_LossContingenciesLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Commitments and Contingencies2false 4us-gaap_LossContingencyDamagesPaidValueus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7truefalsefalse90000009000000USD$falsetruefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of damages paid to the plaintiff in the legal matter.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14326-108349 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 9 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14557-108349 false2Amount paid for settlement3false 4evh_LossContingencyTermOfCorporateIntegrityAgreementevh_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse005 yearsfalsefalsefalse9falsefalsefalse005 yearsfalsefalsefalse10falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaRepresents the term of Corporate Integrity Agreement (CIA).No definition available.false0Term of CIA4false 4us-gaap_LossContingencySettlementAgreementConsideration1us-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse5210000052100000falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10truefalsefalse27000002700000falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of consideration the entity has agreed to pay to settle a legal matter.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14326-108349 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 9 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14557-108349 false2Settlement amount to resolve the claims5false 4evh_GainLossOnPaymentOfDissentingShareholderSettlementevh_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1371700013717000falsefalsefalse2truefalsefalse1371700013717000falsefalsefalse3truefalsefalse1370000013700000falsefalsefalse4truefalsefalse1370000013700000falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the amount of gain (loss) on settlement of dissenting shareholders.No definition available.false2Payment of dissenting shareholder settlement6false 4evh_PaymentsOfDissentingShareholderSettlementevh_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse3833600038336000falsefalsefalse2truefalsefalse3833600038336000falsefalsefalse3truefalsefalse3830000038300000falsefalsefalse4truefalsefalse3830000038300000falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the amount paid to dissenting shareholders on settlement.No definition available.false2Payment of dissenting shareholder settlement7false 4evh_LossContingencyNumberOfLawsuitsPurportingToBeClassActionsFiledevh_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6truefalsefalse44falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalsexbrli:integerItemTypeintegerRepresents the number of lawsuits purporting to be class actions filed during the period.No definition available.false256Number of lawsuits purporting to be class actions filed8false 4us-gaap_LitigationSettlementExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse84000008400000falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the expenses incurred by the entity which are directly related and attributable to receiving an award in settlement of litigation.No definition available.false2Legal settlement costs9false 4evh_LossContingencyAccrualInterestevh_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse19000001900000USD$falsetruefalse4truefalsefalse19000001900000USD$falsetruefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the amount of accrued interest included in reserve for unpaid merger consideration.No definition available.false2Accrued interest included in reserve for unpaid merger considerationfalseCommitments and Contingencies (Details) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.envisionhealthcare.net/role/DisclosureCommitmentsAndContingenciesDetails109